Solvonis Therapeutics (SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (“CNS”) disorders, announced the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.
Solvonis Therapeutics (SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (“CNS”) disorders, announced the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.
KEFI (KEFI), a gold and copper exploration and development company focused on the Arabian-Nubian Shield with a pipeline of projects in the Federal Democratic Republic of Ethiopia, and the Kingdom of
Eco Buildings Group PLC (AIM: ECOB) shares soared nearly 90% in early Tuesday trading after the UK-based sustainable modular construction company announced a landmark €420 million contract with the Chilean
(Alliance News) – The UK economy achieved minor growth in August, numbers on Wednesday showed, aided by a rise in production. The Office for National Statistics said UK gross domestic product
Oxford BioDynamics (OBD), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on its EpiSwitch® 3D genomics platform, noted the publication today of “Prostate
Yesterday MAST Energy Developments (MAST) announced that it has been made aware of articles recommending the Company and its shares to investors which appear to be “sponsored articles” on websites
The Telegraph: Rayner used disabled son’s NHS compensation to buy second home. The Deputy Prime Minister sold share of her Ashton-under-Lyne house to child’s trust for £162,500.
Pri0r1ty (PR1 ) said that further to the announcement on 25 June 2025 regarding the disposal by Primorus Investments (PRIM) of its shareholding in the Company, Pri0r1ty Intelligence Group PLC (AIM:
The FTSE 100 ends the week on a high and hits a seven-week closing peak. The UK stock market wrapped up the week on a brighter note, with the FTSE 100
(Alliance News) UK gross domestic product is estimated to have grown by 0.7% in the quarter from January to March, according to data from the Office for National Statistics on Thursday.
Avacta Therapeutics (AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, announced preclinical results from its second pre|CISION® candidate FAP-EXd
FCA To Cut Red Tape